Business Description
Mono Pharmacare Ltd
ISIN : INE0OIP01012
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.22 | |||||
Debt-to-Equity | 2.92 | |||||
Debt-to-EBITDA | 13.32 | |||||
Interest Coverage | 2.35 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.48 | |||||
Beneish M-Score | 592.73 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.05 | |||||
9-Day RSI | 44.8 | |||||
14-Day RSI | 46.1 | |||||
6-1 Month Momentum % | -18.07 | |||||
12-1 Month Momentum % | 13.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.82 | |||||
Quick Ratio | 0.85 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 127.97 | |||||
Days Sales Outstanding | 85.49 | |||||
Days Payable | 35.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -11.93 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 8.79 | |||||
Operating Margin % | 4.9 | |||||
Net Margin % | 2.11 | |||||
FCF Margin % | -67.69 | |||||
ROE % | 13.72 | |||||
ROA % | 3.2 | |||||
ROIC % | 6.42 | |||||
ROC (Joel Greenblatt) % | 9.19 | |||||
ROCE % | 16.63 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 52.94 | |||||
PE Ratio without NRI | 52.94 | |||||
PS Ratio | 1.11 | |||||
PB Ratio | 4.76 | |||||
Price-to-Tangible-Book | 4.7 | |||||
EV-to-EBIT | 36.41 | |||||
EV-to-EBITDA | 35.15 | |||||
EV-to-Revenue | 1.8 | |||||
EV-to-FCF | -2.73 | |||||
Price-to-Graham-Number | 3.3 | |||||
Price-to-Net-Current-Asset-Value | 5.26 | |||||
Earnings Yield (Greenblatt) % | 2.75 | |||||
FCF Yield % | -61.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mono Pharmacare Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 584.764 | ||
EPS (TTM) (₹) | 0.697 | ||
Beta | 0 | ||
Volatility % | 72.33 | ||
14-Day RSI | 46.1 | ||
14-Day ATR (₹) | 1.310989 | ||
20-Day SMA (₹) | 36.86 | ||
12-1 Month Momentum % | 13.68 | ||
52-Week Range (₹) | 32 - 75 | ||
Shares Outstanding (Mil) | 17.67 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mono Pharmacare Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mono Pharmacare Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Mono Pharmacare Ltd Frequently Asked Questions
What is Mono Pharmacare Ltd(NSE:MONOPHARMA)'s stock price today?
When is next earnings date of Mono Pharmacare Ltd(NSE:MONOPHARMA)?
Does Mono Pharmacare Ltd(NSE:MONOPHARMA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |